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Background
Resistance of Klebsiella pneumoniae to carbapenems is
mainly associated with acquired carbapenem-hydrolyzing
b-lactamases [1]. These b-lactamases can be metallo
b-lactamases (IMP, VIM), expanded-spectrum oxacilli-
nases (OXA-48), or Ambler class A enzymes (NMCA,
IMI, SME, GES, and KPC) [1,2]. The most common class
A carbapenemases in K. pneumoniae are the K. pneumo-
niae carbapenemases (KPCs) [2]. Adequate detection of
carbapenems resistence genes, such as blaKPCis crucial
for infection control measures and appropriate choice of
antimicrobial therapy [3]. In Dourados/MS there are no
reports on the monitoring of KPC-producing multiresis-
tant strains of clinical interest. The aim of this study was
to identify the gene blaKPC in strains of Klebsiella
pneumoniae.
Methods
The samples were collected during February-May/2012
from patients attended at University hospital, Dourados/
MS and identified by classical bacteriological methods.
The strains were most frequently obtained from the urin-
ary tract, vaginal secretion, nasal and rectal swab. Antibio-
grams were realized by using the disk-diffusion method on
Mueller-Hinton agar (Bio-Rad Laboratories), and suscept-
ibility break points were determined as previously
described and interpreted as recommended by the Clinical
and Laboratory Standards Institute [4]. All strains with
reduced susceptibility to imipenem or meropenem (MIC,
≥ 2 μg/mL) were screened for carbapenemase production
by the modified Hodge test. The presence of gene coding
for KPC, were assessed by PCR as described by Cuzon et
al., (2010) [5].
Results and conclusions
From October 2012 to April 2013, 26 strains of K. pneu-
moniae carbapenemase from patients were isolated.
Among the wards, those that had a higher incidence of
samples were recovered from intensive care units (ICUs)
of the hospital, probably due to immune deficiency of
patients, submitted to invasive therapeutic procedures.
The strains identified as producing carbapenemases were
evaluated by PCR amplification using primers specific for
blaKPC gene. Five K. pneumoniae carbapenemase strains
were positive in PCR. Eighteen strains were positive to
modified Hodge test, but were PCR negative. This profile
difference could be due to the presence of other classes of
carbapenemases. Thus, these eighteen strains of K. pneu-
moniae carbapenemase need to be tested for the presence
of b-lactamases such as IMP, VIM, OXA, and NDM-1.
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